<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Arthroplasty</journal-id><journal-id journal-id-type="iso-abbrev">J Arthroplasty</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>The Journal of arthroplasty</journal-title></journal-title-group><issn pub-type="ppub">0883-5403</issn><issn pub-type="epub">1532-8406</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC9979100</article-id><article-id pub-id-type="pmcid-ver">PMC9979100.1</article-id><article-id pub-id-type="pmcaid">9979100</article-id><article-id pub-id-type="pmcaiid">9979100</article-id><article-id pub-id-type="manuscript-id">NIHMS1869752</article-id><article-id pub-id-type="pmid">35931269</article-id><article-id pub-id-type="doi">10.1016/j.arth.2022.07.018</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1869752</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1869752</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Rates and Outcomes of Periprosthetic Joint Infection in Persons Who Inject Drugs</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Humphrey</surname><given-names initials="TJ">Tyler J.</given-names></name><degrees>BA</degrees><xref rid="A1" ref-type="aff">a</xref><xref rid="FN2" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tatara</surname><given-names initials="AM">Alexander M.</given-names></name><degrees>MD, PhD</degrees><xref rid="A2" ref-type="aff">b</xref><xref rid="A3" ref-type="aff">c</xref><xref rid="FN2" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bedair</surname><given-names initials="HS">Hany S.</given-names></name><degrees>MD</degrees><xref rid="A1" ref-type="aff">a</xref><xref rid="A4" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Alpaugh</surname><given-names initials="K">Kyle</given-names></name><degrees>MD</degrees><xref rid="A1" ref-type="aff">a</xref><xref rid="A4" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Melnic</surname><given-names initials="CM">Christopher M.</given-names></name><degrees>MD</degrees><xref rid="A1" ref-type="aff">a</xref><xref rid="A4" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nelson</surname><given-names initials="SB">Sandra B.</given-names></name><degrees>MD</degrees><xref rid="A2" ref-type="aff">b</xref><xref rid="A4" ref-type="aff">d</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="A1"><label>a</label>Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, Massachusetts</aff><aff id="A2"><label>b</label>Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts</aff><aff id="A3"><label>c</label>Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts</aff><aff id="A4"><label>d</label>Harvard Medical School, Boston, Massachusetts</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1">Author Contribution: A.M.T., C.M.M., and S.B.N. conceived the study. T.J.H., A.M.T., C. M.M., and S.B.N. contributed substantially to study design. T.J.H. performed the experimentation and data acquisition. T.J.H., A.M.T., H.S.B., K.A., C.M.M., and S.B.N. contributed to data analysis and interpretation. T.J.H., A.M.T., H.S.B., K.A., C.M.M., and S.B.N. contributed to manuscript preparation. All authors approved the final manuscript.</p></fn><fn fn-type="equal" id="FN2"><label>1</label><p id="P2">TJH and AMT contributed equally to this paper.</p></fn><corresp id="CR1"><label>*</label>Address correspondence to: Sandra B. Nelson, Massachusetts General Hospital, Division of Infectious Diseases, 55 Fruit Street, Boston, MA 02114.</corresp><fn fn-type="COI-statement" id="FN3"><p id="P28">One or more of the authors of this paper have disclosed potential or pertinent conflicts of interest, which may include receipt of payment, either direct or indirect, institutional support, or association with an entity in the biomedical field which may be perceived to have potential conflict of interest with this work. For full disclosure statements refer to <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="10.1016/j.arth.2022.07.018" ext-link-type="doi">https://doi.org/10.1016/j.arth.2022.07.018</ext-link>.</p></fn></author-notes><pub-date pub-type="ppub"><month>1</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>03</day><month>8</month><year>2022</year></pub-date><volume>38</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">430163</issue-id><fpage>152</fpage><lpage>157</lpage><pub-history><event event-type="nihms-submitted"><date><day>17</day><month>02</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>01</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 04:25:40.080"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1869752.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P3">The risk of periprosthetic joint infection (PJI) is higher in persons who inject drugs (PWID) after total joint arthroplasty (TJA), though reported rates vary widely. This study was designed to assess outcomes of TJA in PWID and to describe factors associated with improved PJI outcomes among PWID.</p></sec><sec id="S2"><title>Methods:</title><p id="P4">A retrospective matched cohort study was performed using a 1:4 match among those with and those without a history of injection drug use (IDU) undergoing TJA. Demographic, surgical, and outcome variables were compared in multivariate logistic regressions to determine PJI predictors. Kaplan-Meier analyses were constructed to characterize the difference in survival of patients who did not have PJI or undergo joint explantation between PWID and the matching cohort.</p></sec><sec id="S3"><title>Results:</title><p id="P5">PWID had a 9-fold increased risk of PJI compared to the matched cohort (odds ratio 9.605, 95% CI 2.781&#8211;33.175, <italic toggle="yes">P</italic> &lt; .001). Ten of 17 PWID <italic toggle="yes">whose last use was within 6 months</italic> (active use) of primary TJA had a PJI, while 7 of 41 PWID who did not have active use developed a PJI. Of PWID with PJI, treatment failure was seen in 15 of 17, while in patients who did not have an IDU history, 5 of 8 with PJI had treatment failure.</p></sec><sec id="S4"><title>Conclusion:</title><p id="P6">IDU is a significant risk factor for PJI following TJA. Future work investigating the effect of a multidisciplinary support team to assist in cessation of IDU and to provide social support may improve outcomes and reduce morbidity in this vulnerable population.</p></sec></abstract><kwd-group><kwd>periprosthetic joint infection</kwd><kwd>injection drug use</kwd><kwd>persons who inject drugs</kwd><kwd>total knee arthroplasty</kwd><kwd>total hip arthroplasty</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>